ASSELTA, ROSANNA
 Distribuzione geografica
Continente #
NA - Nord America 9.413
AS - Asia 2.381
EU - Europa 1.900
SA - Sud America 583
AF - Africa 364
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 14.656
Nazione #
US - Stati Uniti d'America 9.319
SG - Singapore 1.291
CN - Cina 821
BR - Brasile 513
FI - Finlandia 468
IE - Irlanda 349
NG - Nigeria 331
IT - Italia 239
DE - Germania 214
FR - Francia 169
NL - Olanda 108
GB - Regno Unito 93
SE - Svezia 89
CA - Canada 68
HK - Hong Kong 57
RU - Federazione Russa 46
IL - Israele 37
TR - Turchia 30
BE - Belgio 28
AR - Argentina 22
BD - Bangladesh 19
PK - Pakistan 16
IQ - Iraq 15
EC - Ecuador 14
IN - India 14
UA - Ucraina 14
CH - Svizzera 11
MX - Messico 11
RO - Romania 11
UZ - Uzbekistan 11
IR - Iran 10
CO - Colombia 9
MA - Marocco 9
CL - Cile 8
KG - Kirghizistan 8
ZA - Sudafrica 8
AT - Austria 7
EG - Egitto 7
NO - Norvegia 7
VE - Venezuela 7
AU - Australia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
JO - Giordania 5
JP - Giappone 5
MD - Moldavia 5
PE - Perù 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
ES - Italia 4
KR - Corea 4
NP - Nepal 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
BO - Bolivia 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
KZ - Kazakistan 3
LV - Lettonia 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
KE - Kenya 2
NI - Nicaragua 2
PA - Panama 2
PH - Filippine 2
PL - Polonia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
IS - Islanda 1
KH - Cambogia 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TM - Turkmenistan 1
UY - Uruguay 1
VN - Vietnam 1
Totale 14.656
Città #
Wilmington 1.662
Chandler 1.627
San Mateo 695
Shanghai 665
The Dalles 562
Singapore 527
Helsinki 468
Ann Arbor 455
Dublin 347
Benin City 330
Leawood 311
Lawrence 302
Princeton 302
Boardman 293
New York 274
Ashburn 177
Paris 164
Woodbridge 150
Fairfield 143
Amsterdam 97
Milan 77
London 64
Toronto 60
Hong Kong 56
San Diego 55
Seattle 54
Norwalk 48
Beijing 44
Los Angeles 38
São Paulo 38
Abbiategrasso 29
Phoenix 29
Brussels 27
Council Bluffs 27
Kocaeli 24
Moscow 22
Santa Clara 22
Naples 21
Falkenstein 19
Rio de Janeiro 17
Sittingbourne 14
Falls Church 12
Belo Horizonte 11
Curitiba 11
Tashkent 11
Brasília 10
Guangzhou 10
Monmouth Junction 10
Andover 9
Cambridge 9
Des Moines 9
Houston 9
Porto Alegre 9
Quito 9
Redmond 9
Zurich 9
Frankfurt am Main 8
Goiânia 8
Zhengzhou 8
Bishkek 7
Cologno Monzese 7
Dhaka 7
Munich 7
Pune 7
Redwood City 7
Baghdad 6
Hanover 6
Osasco 6
Tappahannock 6
Amman 5
Betim 5
Caxias do Sul 5
Chisinau 5
Henderson 5
Juiz de Fora 5
Maceió 5
Nanjing 5
Oslo 5
Petrópolis 5
Sacramento 5
Santo André 5
São Bernardo do Campo 5
São José dos Campos 5
Tehuacán 5
Vienna 5
Winnipeg 5
Bogotá 4
Bratislava 4
Brighton 4
Gunzenhausen 4
Islamabad 4
Itaquaquecetuba 4
Karachi 4
Lima 4
Nuremberg 4
Piracicaba 4
Reston 4
Ribeirão das Neves 4
Rome 4
Salvador 4
Totale 10.714
Nome #
Identification of a glucocorticoid response element in the human gamma chain fibrinogen promoter 105
Dual Role of G-runs and hnRNP F in the Regulation of a Mutation-Activated Pseudoexon in the Fibrinogen Gamma-Chain Transcript 103
Glucocerebrosidase mutations in primary parkinsonism 95
First independent replication of the involvement of LARS2 in Perrault syndrome by whole-exome sequencing of an Italian family 94
SER252PHE and 776INS3 Mutations in the CHRNA4 Gene are Rare in the Italian ADNFLE Population 93
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants 90
Alport syndrome cold cases: Missing mutations identified by exome sequencing and functional analysis. 89
Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of Aα, Bβ, and γ Chains 87
Genetic Association and Altered Gene Expression of CYBB in Multiple Sclerosis Patients 83
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients 81
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 76
Characterization of miR-634, a microRNA potentially relevant for multiple sclerosis 76
Genetic background and risk of postpartum haemorrhage: results from an Italian cohort of 3219 women. 75
Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern 74
Differential expression of microRNAs in peripheral blood mononuclear cells of Multiple Sclerosis patients 74
A new exon in the 5’ untranslated region of bovine Connexin32 gene 73
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease 73
Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia 72
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. 71
Novel fibrinogen gamma-chain mutation p.Asp342Asn (fibrinogen Pisa) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia 70
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. 70
Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis. *Shared first authorship 69
Afibrinogenemia congenita: l’identificazione di una mutazione missense nell’esone 7 del gene per il beta fibrinogeno suggerisce un ruolo del D-domain nell’assemblaggio della proteina 68
Exploring the global landscape of genetic variation in coagulation factor XI deficiency 68
Identification of the first Alu-mediated large deletion involving the F5 gene in a compound heterozygous patient with severe FV deficiency 67
The molecular basis of quantitative fibrinogen disorders 67
A novel mechanism for congenital afibrinogenemia based on pseudoexon activation in the fibrinogen gamma-chain gene 67
Functional characterization of a novel missense mutation identified in a Turkish patient affected by severe coagulation factor V deficiency 67
Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II 66
Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation 66
Genetic diagnosis of haemophilia and other inherited bleeding disorders 66
A novel 15-kb deletion involving fibrinogen Aalpha-chain gene causes congenital afibrinogenemia as a consequence of uniparental isodisomy of chromosome 4 65
Afibrinogenemia: un possibile modello per lo studio dei meccanismi responsabili del controllo della sintesi, dell'assemblaggio e della secrezione del fibrinogeno nella specie umana 65
A very rare simultaneous presence of a ring chromosome 13 and a splicing site mutation on Factor X gene 65
Analysis of the 16S rRNA gene sequence of the coryneform bacterium associated with hyperkeratotic dermatitis of athymic nude mice and development of a PCR-based detection assay 65
A novel in-frame deletion in the factor V C1 domain associated with severe coagulation factor V deficiency in a Korean family 64
Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency 64
Analisi funzionale del promotore della catena gamma del fibrinogeno umano 64
A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing 64
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest. 64
Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion 63
A new genetic mechanism for congenital afibrinogenemia: maternal uniparental isodisomy for chromosome 4 containing a 15-kb deletion in fibrinogen Aalpha-chain gene 63
Concerns about the mutations identified in a case of familial coagulation factor V deficiency: factor V Stanford 62
Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain 62
Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia 62
Characterization of the genomic structure of the human neuronal nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster and identification of novel intragenic polymorphisms 62
ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy 62
Analisi dei siti di risposta all’interleuchina 6 nel promotore del gene della catena gamma del fibrinogeno umano 61
Eterogeneità allelica della carenza grave di fattore V della coagulazione: ampliamento dello spettro mutazionale ed espressione delle mutazioni missense identificate 61
A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency 61
Common variants in the hemostatic gene pathway contribute to risk of early-onset myocardial infarction in the Italian population 60
The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis 60
The double-faced association of the PRKCA gene with multiple sclerosis 60
Congenital afibrinogenemia caused by uniparental isodisomy of chromosome 4 containing a 15-kb deletion involving fibrinogen Aalpha-chain gene 60
Role of the microRNA-183 family in the pathogenesis of hereditary nonsyndromic hearing loss in the Italian population 60
Alternative splicing and nonsense-mediated decay in the F5 gene 60
Coagulation factor V gene analysis in five Indian patients: identification of three novel small deletions 59
Autosomal recessive deficiencies of coagulation factors 59
Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions. 59
Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation 59
Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation 59
Identificazione della prima mutazione che causa un’alterazione dello splicing dell’mRNA per la catena gamma del fibrinogeno umano in un caso di afibrinogenemia 59
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease 59
A type II mutation (Glu117stop), induction of allele-specific mRNA degradation and factor XI deficiency 59
Afibrinogenemia congenita: nuova mutazione nel gene per la catena Bbeta del fibrinogeno che causa ritenzione intracellulare della molecola 59
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 59
Response: Further thoughts on the "phantom" delta6/7 FXI isoform 58
Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene 58
A functional variant in ERAP1 predisposes to multiple sclerosis 58
Molecular genetics of quantitative fibrinogen disorders 58
Autosomal dominant nocturnal frontal lobe epilepsy: a video-polysomnographic and genetic apprisal of 40 patients and delineation of the epileptic syndrome 58
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases 58
Retrospective evaluation of dysfibrinogenaemic patients in a single centre: clinical features and laboratory findings 58
Disomia uniparentale del cromosoma 4 contenente una nuova delezione nel gene FGA come causa di afibrinogenemia congenita 58
DNAJC12 and dopa-responsive nonprogressive parkinsonism 58
Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis 58
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels 58
Allelic heterogeneity of severe factor V deficiency 57
A new biallelic polymorphism in intron 1 of the CHRNA4 gene may cause erroneous genotyping of a closely linked CA repeat marker 57
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. 57
Mutations in disguise 56
Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene 56
Molecular characterization of six novel mutations causing factor V deficiency 56
Nonenzymatic Polymerization into Long Linear RNA Templated by Liquid Crystal Self-Assembly 56
Not only cancer: The long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis 56
The immunobiology of female predominance in primary biliary cholangitis 55
Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency 55
An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate 55
Characterization of productive and unproductive mRNA splicings in F11: identification of a novel coagulation FXI isoform 55
Meta-analysis of Multiple Sclerosis microarray data reveals dysregulation in RNA splicing regulatory genes 55
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease 55
Factor X Shanghai: a mutation disrupting translocation to the endoplasmic reticulum 54
Phase behavior and critical activated dynamics of limited-valence DNA nanostars 54
Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the gamma-chain (p.Glu275Stop) 54
Identification and characterization of 6 novel genetic defects leading to factor V deficiency 54
Factor V Leiden is associated with premature myocardial infarction 53
cDNA cloning of turtle prion protein 53
First identification of a missense mutation in the D-domain of the fibrinogen beta chain in a case of congenital afibrinogenemia 53
The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease 53
Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on fibrinogen gamma-module 53
Totale 6.444
Categoria #
all - tutte 124.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 0 0 0 19
2020/20213.129 24 28 19 19 29 943 469 236 586 363 38 375
2021/20221.522 38 29 25 347 18 19 77 231 154 150 338 96
2022/20234.409 689 152 399 510 433 361 4 364 789 350 303 55
2023/20242.603 203 256 467 108 99 324 152 212 40 47 292 403
2024/20253.176 125 167 85 107 171 535 212 387 498 889 0 0
Totale 14.858